$MLAB
MESA LABORATORIES INC /CO/

2023 Q1 Form 10-Q Financial Statement

#000143774923002542 Filed on February 06, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4
Revenue $55.59M $54.29M
YoY Change -5.58% -0.75%
Cost Of Revenue $22.39M $21.52M
YoY Change -5.79% -17.44%
Gross Profit $33.20M $32.77M
YoY Change -5.44% 14.45%
Gross Profit Margin 59.72% 60.36%
Selling, General & Admin $27.68M $24.57M
YoY Change -7.87% -5.42%
% of Gross Profit 83.37% 74.98%
Research & Development $5.004M $4.797M
YoY Change -3.38% -7.11%
% of Gross Profit 15.07% 14.64%
Depreciation & Amortization $9.055M $8.580M
YoY Change -63.2% 25.49%
% of Gross Profit 27.27% 26.19%
Operating Expenses $32.68M $29.36M
YoY Change -7.21% -5.7%
Operating Profit $517.0K $3.402M
YoY Change -570.0% -235.43%
Interest Expense -$1.380M $1.162M
YoY Change 11.47% 14.15%
% of Operating Profit -266.92% 34.16%
Other Income/Expense, Net -$794.0K -$1.486M
YoY Change -160.98% -969.01%
Pretax Income -$277.0K $1.916M
YoY Change 502.17% -181.85%
Income Tax -$888.0K $1.465M
% Of Pretax Income 76.46%
Net Earnings $611.0K $451.0K
YoY Change -134.25% -121.89%
Net Earnings / Revenue 1.1% 0.83%
Basic Earnings Per Share $0.08
Diluted Earnings Per Share $0.11 $0.08
COMMON SHARES
Basic Shares Outstanding 5.346M 5.337M
Diluted Shares Outstanding 5.360M

Balance Sheet

Concept 2023 Q1 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $32.91M $26.10M
YoY Change -33.31% -49.52%
Cash & Equivalents $32.91M $26.10M
Short-Term Investments
Other Short-Term Assets $86.07M $3.446M
YoY Change 2204.28% -58.39%
Inventory $34.64M $33.74M
Prepaid Expenses
Receivables $42.55M $42.40M
Other Receivables $0.00 $0.00
Total Short-Term Assets $119.0M $114.2M
YoY Change -4.3% -5.63%
LONG-TERM ASSETS
Property, Plant & Equipment $28.15M $28.26M
YoY Change -1.65% -6.26%
Goodwill $286.4M $285.8M
YoY Change -1.62% -2.63%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $514.7M $10.57M
YoY Change 4250.87% -10.12%
Total Long-Term Assets $542.9M $548.8M
YoY Change -6.89% -8.64%
TOTAL ASSETS
Total Short-Term Assets $119.0M $114.2M
Total Long-Term Assets $542.9M $548.8M
Total Assets $661.8M $663.0M
YoY Change -6.44% -8.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.134M $6.288M
YoY Change -22.32% -19.66%
Accrued Expenses $13.39M $12.61M
YoY Change 15.28% 0.99%
Deferred Revenue $14.41M $14.58M
YoY Change 4.17% 16.83%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $43.36M $41.62M
YoY Change -9.77% -11.03%
LONG-TERM LIABILITIES
Long-Term Debt $183.3M $189.0M
YoY Change -16.07% -17.5%
Other Long-Term Liabilities $268.4M $8.172M
YoY Change 3286.57% -1.94%
Total Long-Term Liabilities $268.4M $8.172M
YoY Change 3286.57% -1.94%
TOTAL LIABILITIES
Total Short-Term Liabilities $43.36M $41.62M
Total Long-Term Liabilities $268.4M $8.172M
Total Liabilities $268.4M $275.8M
YoY Change -14.42% -15.24%
SHAREHOLDERS EQUITY
Retained Earnings $74.20M $74.44M
YoY Change -3.23% -6.13%
Common Stock $332.1M $326.9M
YoY Change 5.94% 6.08%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $393.5M $387.2M
YoY Change
Total Liabilities & Shareholders Equity $661.8M $663.0M
YoY Change -6.44% -8.14%

Cashflow Statement

Concept 2023 Q1 2022 Q4
OPERATING ACTIVITIES
Net Income $611.0K $451.0K
YoY Change -134.25% -121.89%
Depreciation, Depletion And Amortization $9.055M $8.580M
YoY Change -63.2% 25.49%
Cash From Operating Activities $12.52M $7.718M
YoY Change 34.58% -51.45%
INVESTING ACTIVITIES
Capital Expenditures $1.026M $1.654M
YoY Change -231.2% -180.33%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$4.950M
YoY Change -98.35%
Cash From Investing Activities -$1.026M -$6.604M
YoY Change 31.2% -97.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -4.392M -8.883M
YoY Change -56.29% -114.51%
NET CHANGE
Cash From Operating Activities 12.52M 7.718M
Cash From Investing Activities -1.026M -6.604M
Cash From Financing Activities -4.392M -8.883M
Net Change In Cash 7.101M -7.769M
YoY Change -565.03% -96.56%
FREE CASH FLOW
Cash From Operating Activities $12.52M $7.718M
Capital Expenditures $1.026M $1.654M
Free Cash Flow $11.49M $6.064M
YoY Change 13.97% -66.23%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
36946000 usd
CY2022Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
39224000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8172000 usd
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7924000 usd
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
758000 usd
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
630000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
19708000 usd
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
17726000 usd
CY2022Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2022Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5341890
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5265627
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5265627
CY2022Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.16
CY2022Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.16
CY2022Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.16
CY2021Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.16
CY2021Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.16
CY2021Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.16
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-11740
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
CO
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-0872291
dei Entity Address Address Line1
EntityAddressAddressLine1
12100 West Sixth Avenue
dei Entity Address City Or Town
EntityAddressCityOrTown
Lakewood
dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80228
dei City Area Code
CityAreaCode
303
dei Local Phone Number
LocalPhoneNumber
987-8000
dei Security12b Title
Security12bTitle
Common Stock, no par value
dei Trading Symbol
TradingSymbol
MLAB
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5346174
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26101000 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
49346000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
42395000 usd
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
41224000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
33739000 usd
CY2022Q1 us-gaap Inventory Net
InventoryNet
24606000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
11950000 usd
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9142000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
114185000 usd
CY2022Q1 us-gaap Assets Current
AssetsCurrent
124318000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28263000 usd
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28620000 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
708000 usd
CY2022Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1318000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10572000 usd
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
11830000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
223447000 usd
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
250117000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
285809000 usd
CY2022Q1 us-gaap Goodwill
Goodwill
291166000 usd
CY2022Q4 us-gaap Assets
Assets
662984000 usd
CY2022Q1 us-gaap Assets
Assets
707369000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6288000 usd
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
7897000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8134000 usd
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
14717000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
14584000 usd
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
13830000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12611000 usd
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11611000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
41617000 usd
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
48055000 usd
CY2022Q4 us-gaap Line Of Credit
LineOfCredit
19000000 usd
CY2022Q1 us-gaap Line Of Credit
LineOfCredit
49000000 usd
CY2022Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
170044000 usd
CY2022Q1 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
169365000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
275779000 usd
CY2022Q1 us-gaap Liabilities
Liabilities
313568000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
326933000 usd
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
313460000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
74444000 usd
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
76675000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-14172000 usd
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3666000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
387205000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
393801000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
662984000 usd
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
707369000 usd
CY2022Q4 us-gaap Cost Of Revenue
CostOfRevenue
21522000 usd
CY2021Q4 us-gaap Cost Of Revenue
CostOfRevenue
26069000 usd
us-gaap Cost Of Revenue
CostOfRevenue
62997000 usd
us-gaap Cost Of Revenue
CostOfRevenue
51478000 usd
CY2022Q4 us-gaap Gross Profit
GrossProfit
32765000 usd
CY2021Q4 us-gaap Gross Profit
GrossProfit
28627000 usd
us-gaap Gross Profit
GrossProfit
100492000 usd
us-gaap Gross Profit
GrossProfit
73978000 usd
CY2022Q4 us-gaap Selling Expense
SellingExpense
8437000 usd
CY2021Q4 us-gaap Selling Expense
SellingExpense
8958000 usd
us-gaap Selling Expense
SellingExpense
27660000 usd
us-gaap Selling Expense
SellingExpense
18459000 usd
CY2022Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16129000 usd
CY2021Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17017000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
54543000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
40119000 usd
CY2022Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4797000 usd
CY2021Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5164000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15486000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10588000 usd
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
29363000 usd
CY2021Q4 us-gaap Operating Expenses
OperatingExpenses
31139000 usd
us-gaap Operating Expenses
OperatingExpenses
97689000 usd
us-gaap Operating Expenses
OperatingExpenses
69166000 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
3402000 usd
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-2512000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
2803000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
4812000 usd
CY2022Q4 us-gaap Interest Expense
InterestExpense
1162000 usd
CY2021Q4 us-gaap Interest Expense
InterestExpense
1018000 usd
us-gaap Interest Expense
InterestExpense
3390000 usd
us-gaap Interest Expense
InterestExpense
2647000 usd
CY2022Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-324000 usd
CY2021Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1189000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
475000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1455000 usd
CY2022Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1486000 usd
CY2021Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
171000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2915000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1192000 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1916000 usd
CY2021Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2341000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-112000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3620000 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1465000 usd
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-281000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-431000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-35000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
451000 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-2060000 usd
us-gaap Net Income Loss
NetIncomeLoss
319000 usd
us-gaap Net Income Loss
NetIncomeLoss
3655000 usd
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.39
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.70
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.39
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.69
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5339000
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5233000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5312000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5199000
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5360000
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5233000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5354000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5333000
CY2022Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
451000 usd
CY2021Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2060000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
319000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3655000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
11345000 usd
CY2021Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-6165000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-17838000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-7297000 usd
CY2022Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
11796000 usd
CY2021Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8225000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17519000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3642000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
319000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3655000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
24769000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
15686000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
9859000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
7939000 usd
mlab Amortization Of Inventory Stepup Cost
AmortizationOfInventoryStepupCost
0 usd
mlab Amortization Of Inventory Stepup Cost
AmortizationOfInventoryStepupCost
6062000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
359000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
504000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1979000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2258000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
9191000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-351000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2312000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1933000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1339000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1270000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-5221000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1403000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
918000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
1056000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
15464000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
29921000 usd
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
4950000 usd
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
300793000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3518000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3650000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8468000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-304443000 usd
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
0 usd
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
70000000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
30000000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
10000000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
2550000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
2495000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4523000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
6171000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
909000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
819000 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
-0 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
234000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-28936000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
62623000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-1305000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-260000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-23245000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-212159000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
49346000 usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
263865000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
26101000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
51706000 usd
mlab Noncash Or Part Noncash Acquisition Contingent Consideration Assumed
NoncashOrPartNoncashAcquisitionContingentConsiderationAssumed
1500000 usd
mlab Noncash Or Part Noncash Acquisition Contingent Consideration Assumed
NoncashOrPartNoncashAcquisitionContingentConsiderationAssumed
0 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
393801000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1438000 usd
CY2022Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
2000 usd
CY2022Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
843000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3432000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-15957000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1438000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
380431000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2778000 usd
CY2022Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
572000 usd
CY2022Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
852000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4371000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-13226000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
1306000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
374236000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
307000 usd
CY2022Q4 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
335000 usd
CY2022Q4 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
855000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2056000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
11345000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
451000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
387205000 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
406227000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1836000 usd
CY2021Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
747000 usd
CY2021Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
824000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2197000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
5371000 usd
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1995000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
399003000 usd
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2060000 usd
CY2021Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
68000 usd
CY2021Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
834000 usd
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2039000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-6503000 usd
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3720000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
399417000 usd
CY2021Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2275000 usd
CY2021Q4 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
4000 usd
CY2021Q4 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
837000 usd
CY2021Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3703000 usd
CY2021Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-6165000 usd
CY2021Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2060000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
396329000 usd
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"/> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><i><b>Prior Period Reclassification</b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Certain amounts presented for prior periods in Note <em style="font: inherit;">3.</em> "Revenue Recognition" have been reclassified. Certain revenues related to the Biopharmaceutical Development division have been reclassified out of revenues from consumables and into revenues from hardware and services. Certain revenues related to the Clinical Genomics division have been reclassified out of revenues from hardware and into revenues from consumables. These reclassifications have <em style="font: inherit;">not</em> resulted in any change to the Condensed Consolidated Financial Statements for and periods presented in this Form <em style="font: inherit;">10</em>-Q.</p>
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
16233000 usd
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
14717000 usd
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
54287000 usd
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
54696000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
163489000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
125456000 usd
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
54287000 usd
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
54696000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
163489000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
125456000 usd
CY2022Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
15069000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
7927000 usd
mlab Contract With Customer Liability Increase During Period Net Of Revenue Recognized
ContractWithCustomerLiabilityIncreaseDuringPeriodNetOfRevenueRecognized
9091000 usd
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
20122000 usd
CY2022Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
14172000 usd
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1972000 usd
CY2022Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
4419000 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
11645000 usd
CY2022Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
6015000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
33739000 usd
CY2022Q1 us-gaap Inventory Net
InventoryNet
24606000 usd
CY2022Q4 mlab Prepaid Expenses Current
PrepaidExpensesCurrent
3450000 usd
CY2022Q1 mlab Prepaid Expenses Current
PrepaidExpensesCurrent
2871000 usd
CY2022Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
1702000 usd
CY2022Q1 us-gaap Deposits Assets Current
DepositsAssetsCurrent
1410000 usd
CY2022Q4 us-gaap Prepaid Taxes
PrepaidTaxes
3352000 usd
CY2022Q1 us-gaap Prepaid Taxes
PrepaidTaxes
2536000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3446000 usd
CY2022Q1 us-gaap Other Assets Current
OtherAssetsCurrent
2325000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
11950000 usd
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9142000 usd
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.39
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.70
CY2022Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
2926000 usd
CY2022Q1 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
3677000 usd
CY2022Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
1773000 usd
CY2022Q1 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
2069000 usd
CY2022Q4 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
721000 usd
CY2022Q1 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
1503000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8134000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
328028000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
104581000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
223447000 usd
CY2022Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
335400000 usd
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
85283000 usd
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
250117000 usd
CY2022Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7147000 usd
CY2021Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5922000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
21573000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
13495000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
7250000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
28490000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
26911000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
26149000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
25652000 usd
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2022Q1 us-gaap Goodwill
Goodwill
291166000 usd
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-8444000 usd
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
2973000 usd
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
114000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
285809000 usd
CY2022Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2056000 usd
CY2021Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3703000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9859000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7939000 usd
CY2022Q4 mlab Employee Service Sharebased Compensation Tax Expense Benefit From Compensation Expense
EmployeeServiceSharebasedCompensationTaxExpenseBenefitFromCompensationExpense
226000 usd
CY2021Q4 mlab Employee Service Sharebased Compensation Tax Expense Benefit From Compensation Expense
EmployeeServiceSharebasedCompensationTaxExpenseBenefitFromCompensationExpense
-743000 usd
mlab Employee Service Sharebased Compensation Tax Expense Benefit From Compensation Expense
EmployeeServiceSharebasedCompensationTaxExpenseBenefitFromCompensationExpense
-1855000 usd
mlab Employee Service Sharebased Compensation Tax Expense Benefit From Compensation Expense
EmployeeServiceSharebasedCompensationTaxExpenseBenefitFromCompensationExpense
-4247000 usd
CY2022Q4 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
2282000 usd
CY2021Q4 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
2960000 usd
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
8004000 usd
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
3692000 usd
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.39
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.69
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
202000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
167.14
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y10M24D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
18261000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
43000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
185.61
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
7000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
225.12
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
45000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
100.19
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
193000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
184.70
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y1M6D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3406000 usd
CY2022Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
451000 usd
CY2021Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2060000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
319000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3655000 usd
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5339000
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5233000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5312000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5199000
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5360000
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5233000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5354000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5333000
CY2022Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
833000
CY2021Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
933000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
818000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
664000
CY2022Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.765 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
3.848 pure
CY2021Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.120 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.010 pure
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022Q4 us-gaap Gross Profit
GrossProfit
32765000 usd
CY2021Q4 us-gaap Gross Profit
GrossProfit
28627000 usd
us-gaap Gross Profit
GrossProfit
100492000 usd
us-gaap Gross Profit
GrossProfit
73978000 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1916000 usd
CY2021Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2341000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-112000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3620000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
33739000 usd
CY2022Q1 us-gaap Inventory Net
InventoryNet
24606000 usd

Files In Submission

Name View Source Status
0001437749-23-002542-index-headers.html Edgar Link pending
0001437749-23-002542-index.html Edgar Link pending
0001437749-23-002542.txt Edgar Link pending
0001437749-23-002542-xbrl.zip Edgar Link pending
ex_448735.htm Edgar Link pending
ex_448736.htm Edgar Link pending
ex_448737.htm Edgar Link pending
ex_448738.htm Edgar Link pending
ex_466624.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image01.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
mlab-20221231.xsd Edgar Link pending
mlab20221231_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
mlab-20221231_lab.xml Edgar Link unprocessable
mlab-20221231_cal.xml Edgar Link unprocessable
mlab20221231_10q_htm.xml Edgar Link completed
mlab-20221231_pre.xml Edgar Link unprocessable
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
sig01.jpg Edgar Link pending
sig02.jpg Edgar Link pending
sig03.jpg Edgar Link pending
sig04.jpg Edgar Link pending
sig05.jpg Edgar Link pending
mlab-20221231_def.xml Edgar Link unprocessable